Part
01
of one
Part
01
Global IV Therapy Market, Part 2 (2)
Key Takeaways
- Fresenius Se & co. KGAA is a global healthcare group that offers "high-quality products and services for dialysis, hospitals, and outpatient treatment."
- Pfizer Inc. is a global biopharmaceutical company that delivers innovative therapies to improve/extend lives.
- Becton, Dickinson and Company is a global medical technology company that provides "innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes."
- Terumo Medical Corporation is a global leader in medical technology and one of the world’s leading medical devices and supplies manufacturers.
- B. Braun is a global "leader in infusion therapy and pain management."
- According to MarketWatch, a competitive rivalry exists among the five top companies in the global IV therapy market.
Introduction
This report presents five top competitors in the global IV therapy market, which are Fresenius Se & co. KGAA, Pfizer Inc., Becton, Dickinson and Company, Terumo Medical Corporation, and B. Braun. Some information, especially the company's overview, has been provided verbatim.
Top Competitors in the Global Intravenous (IV) Therapy Market
1. Fresenius Se & co. KGAA
- The website of Fresenius Se & co. KGAA can be accessed via this link. The company is headquartered in Bad Homburg, Germany.
- Fresenius Se & co. KGAA is a global healthcare group that offers "high-quality products and services for dialysis, hospitals, and outpatient treatment." Fresenius Kabi is a subsidiary of Fresenius Se & co. KGAA health care group, which supplies drugs, clinical nutrition products, medical devices, and services to critically and chronically ill patients.
- According to MarketWatch, Fresenius Se & co. KGAA is an industry leader owing to its significant revenue share. It generated £36,277 million in 2020.
- Fresenius Se & co. KGAA offers innovative IV bags (Freeflex) for "leak prevention, sterility protection, and needle-stick prevention." The company also sells base solutions products such as 0.9% Sodium Chloride Injection, USP, 5% Dextrose Injection, USP, Lactated Ringer’s Injection, USP, and 0.45% Sodium Chloride Injection, USP, among others.
- Some of the company's products for intravenous use include Perikabiven (Amino acids, electrolytes, dextrose, and lipid injectable emulsion) and Kabiven (Amino acids, electrolytes, dextrose, and lipid injectable emulsion).
2. Pfizer Inc.
- Pfizer Inc. is a global biopharmaceutical company that delivers innovative therapies to improve/extend lives. The company is headquartered in New York, United States.
- According to MarketWatch, Pfizer Inc. is an industry leader due to its significant revenue share — it amounted to $41.9 billion in 2020.
- The U.S. Food and Drug Administration (FDA) approved Pfizer Inc. to offer PANZYGA (the only FDA-approved intravenous immunoglobulin) to treat patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Besides, Heparin Sodium in Sodium Chloride Injection, Heparin Sodium In Dextrose Injection, Heparin Sodium In 5% Dextrose Injection are used for intravenous use. Nivestym and IXIFI (infliximab-qbtx) Lyophilized Concentrate for Injection are other Pfizer's products for intravenous use. Some more information on Pfizer Inc.'s IV therapy can be accessed here.
3. Becton, Dickinson and Company
- Becton, Dickinson and Company is a global medical technology company that provides "innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes." The company's official website can be accessed here.
- According to MarketWatch, Becton, Dickinson and Company is an industry leader owing to its significant revenue share. In 2020, its revenue amounted to $17,117 million.
- Becton, Dickinson and Company provides IV solutions (IV fluids) including "pumps, software, interoperability, and vascular access devices and accessories" to improve patients' safety. The company offers needle-free systems & connectors and dedicated disposables.
4. Terumo Medical Corporation
- Terumo Medical Corporation is a global leader in medical technology and one of the world’s leading medical devices and supplies manufacturers. Terumo Medical Corporation is a subsidiary of Terumo Corporation. Terumo Corporation has four selling divisions; namely, Terumo Interventional Systems, Terumo Medical Products, Terumo Pharmaceutical Solutions, and Terumo Business Edge. The company's official website can be accessed here.
- According to MarketWatch, Terumo Medical Corporation is an industry leader owing to its significant revenue share. In 2020, the group's annual revenue amounted to 628,897 million yens, with about $750 million being attributed to Terumo Medical Corporation.
- The company manufactures and sells intravenous solutions in soft plastic bags to reduce risks of microbiological contamination. IV catheters are some intravenous solutions invented by Terumo Medical Corporation. The company also offers infusion and blood collection products.
5. B. Braun
- B. Braun is a global "leader in infusion therapy and pain management." The company's website can be accessed via this link.
- According to MarketWatch, B. Braun is an industry leader due to its significant revenue share. In 2020, its annual revenue amounted to €7.4 billion.
- The company offers a full line of IV solution products manufactured using non-toxic plastic materials, such as E3 IV containers. B. Braun is FDA-approved to provide 5% Dextrose and 0.45% Sodium Chloride Injection USP in 1L IV containers. IV catheter with injection port is one of the products offered by B. Braun. More products can be accessed here.
Research Strategy
For this research on five top competitors in the global IV therapy market, we leveraged the most reputable sources of information available in the public domain, including MarketWatch, annual reports, catalogue/product pages, LinkedIn, and third-party sources such as Growjo, among others. We relied on experts' opinion to determine the "Top" competitors, which were major market players with significant revenue share. More to that, some information, especially the company's overview, has been provided verbatim and the revenues' currencies were not converted. Notably, Fresenius Kabi is a subsidiary of Fresenius Se & co. KGAA health care group, which supplies drugs, clinical nutrition products, medical devices, and services to critically and chronically ill patients; hence, we listed some service offerings by Fresenius Kabi.